Income statement, balance sheet and cash flow are moderate.
Next earnings: 2026-10-21 (BMO), EPS Forecast: $6.40
Downgraded from Hold to Sell in the Jul 2023 quarter: 60.8 → 58.4 (-2.4). This quarter: +2.3.
Change vs previous quarter.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.